ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1,2,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2,3,Headache,Headaches NEC,Headaches,Nerv,N
2,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
4,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Deafness,Hearing losses,Hearing disorders,Ear,N
6,1,Deafness,Hearing losses,Hearing disorders,Ear,N
7,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
7,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
9,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
10,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
11,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
12,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
13,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
13,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
14,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
14,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
15,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
16,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
17,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
18,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
19,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
20,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
21,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
22,1,Deafness,Hearing losses,Hearing disorders,Ear,N
22,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
22,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
24,1,Peritoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,Y
25,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
26,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
27,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
28,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
28,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
29,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
30,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
31,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
31,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
31,3,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
32,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,2,Headache,Headaches NEC,Headaches,Nerv,N
32,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
32,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
34,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
34,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
35,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
35,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
36,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
36,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
38,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
40,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
40,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
40,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
41,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
42,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
42,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
42,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
43,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
44,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
44,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
45,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
46,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
46,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
48,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
48,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
48,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
48,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,1,Deafness,Hearing losses,Hearing disorders,Ear,N
50,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
50,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
52,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
53,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
53,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
53,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
54,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
54,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
55,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
56,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
57,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
57,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
57,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
57,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
58,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
59,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
60,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
60,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
60,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
61,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
62,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
62,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
62,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
63,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
63,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
63,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,5,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
63,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
64,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
65,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
66,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
67,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
68,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
69,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
70,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
70,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
71,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
72,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
72,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
72,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
73,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
74,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
76,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
77,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
78,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
79,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
80,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
80,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
80,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
81,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
82,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
82,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
83,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
83,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
84,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
86,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
87,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
88,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
88,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
89,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
90,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
91,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
91,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
91,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
92,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
93,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
94,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Deafness,Hearing losses,Hearing disorders,Ear,N
95,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
96,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
96,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
97,1,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
98,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
99,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
99,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
100,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
101,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
101,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
102,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
102,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
103,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
103,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
103,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
105,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
106,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
106,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
107,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
107,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
108,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
108,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
108,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
109,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
109,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
109,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
109,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
110,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
110,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
111,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
111,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
111,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
112,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
112,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
112,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
112,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
112,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
112,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
114,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
114,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
115,1,Deafness,Hearing losses,Hearing disorders,Ear,N
115,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
116,1,Amaurosis fugax,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
117,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
118,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
119,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
119,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
119,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
121,1,Deafness,Hearing losses,Hearing disorders,Ear,N
122,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
122,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
123,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
124,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
124,2,Dermatitis herpetiformis,Bullous conditions,Epidermal and dermal conditions,Skin,N
124,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
124,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
124,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
125,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
125,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
126,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
126,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
127,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
128,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
128,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
129,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
129,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
130,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
131,1,Deafness,Hearing losses,Hearing disorders,Ear,N
131,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
132,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
133,1,Deafness,Hearing losses,Hearing disorders,Ear,N
133,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
134,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
134,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
134,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
134,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
136,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
137,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
137,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
138,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
138,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
138,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
139,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,Y
140,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
140,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
140,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
142,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
142,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
143,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
144,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
145,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
146,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
146,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
146,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
147,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
147,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
147,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
147,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
147,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
148,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
149,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
150,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
151,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
152,1,Auriculotemporal syndrome,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
152,2,Deafness,Hearing losses,Hearing disorders,Ear,N
152,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
153,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
153,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
154,1,Headache,Headaches NEC,Headaches,Nerv,N
154,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
155,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
156,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
156,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
157,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
157,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
158,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
158,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
158,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
159,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
159,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
159,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
160,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
161,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
161,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
162,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
162,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
162,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
162,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
162,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
163,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
164,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
164,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
165,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
166,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
166,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
167,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
167,2,Deafness,Hearing losses,Hearing disorders,Ear,N
167,3,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
168,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
169,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
169,2,Facial spasm,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
169,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
169,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
170,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
171,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
171,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
172,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
172,2,Headache,Headaches NEC,Headaches,Nerv,N
172,3,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
172,4,Pituitary apoplexy,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
172,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
172,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
173,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
173,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
174,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
174,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
174,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
174,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
175,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
175,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
175,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
176,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
177,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
179,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
180,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
181,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
181,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
182,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
182,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
182,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
182,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
182,5,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
183,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
183,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
184,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
184,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
184,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
185,1,Thrombosis mesenteric vessel,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
186,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
186,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
186,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
186,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
186,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
187,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
188,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
189,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
190,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
190,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
191,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
191,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
191,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
192,1,Auriculotemporal syndrome,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
193,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
193,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
194,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
195,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
196,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
196,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
197,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
197,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
197,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
197,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
199,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
199,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
199,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
199,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
199,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
200,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
201,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
202,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
202,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
202,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
202,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
204,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
204,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
204,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
205,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
206,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
206,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
206,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,7,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
206,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
206,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
207,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
208,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
208,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,1,Nail dystrophy,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
209,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
210,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
211,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
212,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
212,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
212,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
212,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
212,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
213,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
214,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
215,1,Deafness,Hearing losses,Hearing disorders,Ear,N
215,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
215,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
215,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
216,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
217,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
217,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
217,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
218,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
219,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
220,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
221,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
221,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
221,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
221,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
221,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
221,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
222,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
222,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
223,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
223,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
224,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
225,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
225,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
226,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
227,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
227,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
227,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
227,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
227,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
227,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
228,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
229,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
230,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
230,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
231,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
231,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
231,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
232,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
233,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
234,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
234,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
234,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
234,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
235,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
235,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
235,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
235,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
236,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
236,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
236,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
237,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
237,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
238,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
238,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
238,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
238,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
239,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
240,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
240,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
240,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
241,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
241,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
242,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
242,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
242,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
242,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
243,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
243,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
243,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
243,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
243,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
244,1,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
245,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
245,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
246,1,Androgen deficiency,Male gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
246,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
246,3,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
247,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
247,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
248,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
250,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
251,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
252,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
253,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
254,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
255,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
255,2,Headache,Headaches NEC,Headaches,Nerv,N
255,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
255,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
256,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
256,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
256,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
256,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
256,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
257,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
257,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
257,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
257,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
258,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
259,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
260,1,Deafness,Hearing losses,Hearing disorders,Ear,N
261,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
262,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
262,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
262,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
262,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
262,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
262,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
263,1,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
263,2,Retinal neovascularisation,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
263,3,Sudden visual loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
263,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
264,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
264,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
264,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
264,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
264,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
264,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
265,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
265,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
265,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
265,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
265,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
266,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
266,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
267,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
267,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
268,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
268,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
268,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
268,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
268,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
268,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
269,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
269,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
269,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
270,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
270,2,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
270,3,Retinal neovascularisation,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
271,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
272,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
273,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
273,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
273,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
274,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
274,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
274,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
274,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
275,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
276,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
277,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
278,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
279,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
279,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
279,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
279,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
279,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
279,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
280,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
281,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
281,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
281,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
282,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
283,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
284,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
284,2,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
284,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
284,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
285,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
285,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
285,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
285,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
286,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
286,2,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
287,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
288,1,Headache,Headaches NEC,Headaches,Nerv,N
288,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
289,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
290,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
291,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
291,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
292,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
293,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
293,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,Y
294,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
295,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
296,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
296,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
297,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
297,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
298,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
298,2,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
298,3,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
299,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
299,2,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
299,3,Embolism arterial,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
299,4,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
299,5,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
300,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
300,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
301,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
302,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
303,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
304,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
304,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
305,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
305,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
306,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
307,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
307,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
308,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
309,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
309,2,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
309,3,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
310,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
311,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
312,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
312,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
313,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
313,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
314,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
315,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
316,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
316,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
317,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
317,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
317,3,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
318,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
318,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
319,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
319,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
319,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
320,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
321,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
322,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
322,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
322,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
323,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
323,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
323,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
324,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
324,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
324,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
325,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
325,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
325,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
325,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
325,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
326,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
327,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
327,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
327,3,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
327,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
327,5,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
327,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
327,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
327,8,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
327,9,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
327,10,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
328,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
328,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
329,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
329,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
329,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
329,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
329,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
329,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
329,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
329,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
331,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
332,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
332,2,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
333,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
333,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
335,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
335,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
335,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
336,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
336,2,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
337,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
337,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
338,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
339,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,Y
339,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
340,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
341,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
342,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
343,2,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
344,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
345,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
346,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
347,1,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
347,2,Retinal neovascularisation,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
347,3,Sudden visual loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
347,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
348,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
349,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
349,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
349,3,Headache,Headaches NEC,Headaches,Nerv,N
349,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
349,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
349,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
350,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
350,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
350,3,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
350,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
351,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
351,2,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
352,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
352,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
353,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
354,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
354,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
354,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
354,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
355,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
356,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
356,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
356,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
356,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
356,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
356,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
356,7,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
357,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
358,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
358,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
358,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
359,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
359,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
359,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
359,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
359,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
360,1,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
361,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
362,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
363,1,Epiploic appendagitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
363,2,Gastric volvulus,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
363,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
364,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
365,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
365,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
365,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
366,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
367,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
367,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
367,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
367,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
367,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
367,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
367,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
367,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
367,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
368,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
368,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
368,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
369,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
369,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
370,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
371,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
372,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
373,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
373,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
374,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
375,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
376,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
377,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
378,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
379,1,Device leakage,Device issues NEC,Device issues,Prod,N
379,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
380,1,Device leakage,Device issues NEC,Device issues,Prod,N
380,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
381,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
382,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
382,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
382,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
383,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
384,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
384,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
385,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
386,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
386,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
386,3,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,Y
387,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
388,1,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
388,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
388,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
388,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
389,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
389,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
390,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
390,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
390,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
390,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
390,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
391,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
391,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
391,3,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
391,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
391,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
391,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
391,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
391,8,Pupillary disorder,Pupil disorders,Ocular neuromuscular disorders,Eye,N
391,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
392,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
392,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
392,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
392,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
392,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
393,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
394,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
394,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
395,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
395,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
395,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
395,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
395,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
395,6,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
395,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
396,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
397,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
398,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
398,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
399,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
400,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
401,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
402,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
402,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
402,4,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
403,1,Deafness,Hearing losses,Hearing disorders,Ear,N
404,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
405,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
405,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
405,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
405,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
405,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
405,6,Ileal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
405,7,Jejunal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
405,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
405,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
405,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
405,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
406,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
406,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
406,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
407,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
407,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
408,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
409,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
410,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
410,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
410,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
411,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
412,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
413,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
413,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
414,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
414,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
414,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
414,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
414,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
415,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
415,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
415,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
415,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
415,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
416,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
416,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
416,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
417,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
418,1,Injection site phlebitis,Injection site reactions,Administration site reactions,Genrl,N
418,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
419,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
419,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
420,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
421,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
422,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
422,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
422,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
423,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
424,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
424,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
425,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
425,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
426,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
426,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
426,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
427,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
427,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
428,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
429,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
430,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
431,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
432,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
433,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
434,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
434,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
434,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
435,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
435,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
435,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
435,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
436,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
436,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
437,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
437,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
438,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
438,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
439,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
440,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
441,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
441,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
442,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
443,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
444,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
444,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
444,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
445,1,Deafness,Hearing losses,Hearing disorders,Ear,N
445,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
446,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
446,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
447,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
447,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
447,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
447,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
448,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
448,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
448,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
449,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
449,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
450,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
450,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
450,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
451,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
451,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
451,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
452,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
452,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
452,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
453,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
453,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
453,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
454,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
454,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
455,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
457,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
458,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
458,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
458,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
459,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
459,2,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
460,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
461,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
461,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
461,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
462,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
463,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
464,1,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
464,2,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
465,1,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
465,2,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
466,1,Deafness,Hearing losses,Hearing disorders,Ear,N
466,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
467,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
468,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
468,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
468,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
468,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
468,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
468,6,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
468,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
468,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
468,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
468,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
468,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
469,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
470,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
470,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
470,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
470,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
470,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
470,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
471,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
471,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
471,3,Peripheral embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
472,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
472,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
472,3,Peripheral embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
473,1,Embolism arterial,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
473,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
473,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
474,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
474,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
474,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
474,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
474,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
474,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
474,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
474,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
474,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
474,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
475,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
476,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
477,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
477,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
477,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
477,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
478,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
478,2,Post procedural urine leak,Urinary tract procedural complications,Procedural related injuries and complications NEC,Inj&P,N
479,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
479,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
479,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
479,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
480,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
480,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
481,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
481,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
482,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
482,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
482,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
482,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
482,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
482,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
482,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
483,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
484,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
485,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
486,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
486,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
486,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
486,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
488,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
489,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
489,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
489,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
489,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
490,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
490,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
491,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
492,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
492,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
492,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
492,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
493,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
493,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
494,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
495,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
496,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
497,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
497,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
498,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
498,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
499,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
499,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
499,3,Rickets,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
500,1,Carotid artery dissection,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
500,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
500,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
501,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
502,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
502,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
503,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
504,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
505,1,Dropped head syndrome,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
505,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
505,3,Radiation interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,1,Dropped head syndrome,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
506,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,3,Radiation interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,1,Dropped head syndrome,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
507,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,3,Radiation interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,1,Dropped head syndrome,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
508,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,3,Radiation interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
509,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
509,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
509,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
509,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
509,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
509,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
509,8,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
509,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
509,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
509,11,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
509,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
510,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
511,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
512,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
512,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
513,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
514,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
514,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
514,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
515,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
516,1,Anastomotic leak,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
516,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
517,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
518,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
518,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
518,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
518,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
518,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
519,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
520,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
521,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
521,2,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,Y
521,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
521,4,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
521,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
522,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
522,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
523,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
523,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
523,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
523,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
523,5,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
523,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
524,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
524,2,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
525,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
525,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
525,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
525,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
525,5,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
525,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
527,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
527,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
527,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
527,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
528,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
529,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
529,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
530,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
530,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
531,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
531,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
531,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
531,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
531,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
531,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
531,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
531,8,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
531,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
533,1,Cervix carcinoma stage IV,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
533,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
533,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
533,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
533,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
533,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
534,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
535,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
535,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
535,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
535,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
535,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
536,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
536,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
536,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
537,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
537,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
537,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
537,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
537,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
538,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
538,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
539,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
540,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
540,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
541,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
541,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
542,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
542,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
542,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
542,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
542,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
542,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
542,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
542,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
542,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
542,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
542,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
542,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
542,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
542,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
544,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
544,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
544,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
544,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
544,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
545,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
545,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
545,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
545,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
545,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
545,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
545,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
546,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
546,2,Infected dermal cyst,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
546,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
546,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
546,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
547,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
547,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
547,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
547,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
547,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
547,6,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
547,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
548,1,Chondrosarcoma metastatic,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
548,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
549,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
549,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
550,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
550,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
550,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
550,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
550,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
550,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
551,2,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
551,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
551,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
551,5,Neuroendocrine carcinoma,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
551,6,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
551,7,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
551,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
552,2,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
552,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
552,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
553,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
553,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
554,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
555,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
556,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
557,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
558,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
559,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
560,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
560,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
561,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
562,1,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
563,1,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
564,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
564,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
564,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
564,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
564,5,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
564,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
564,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
564,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
564,9,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
564,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
565,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
566,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
566,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
567,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
568,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
569,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
569,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
570,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
570,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
571,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
571,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
571,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
571,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
571,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
571,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
572,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
572,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
572,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
573,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
573,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
573,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
574,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
574,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
574,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
575,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
575,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
576,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
576,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
576,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
577,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
577,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
577,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
578,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
578,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
579,2,Gallbladder neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
579,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
580,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
580,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
580,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
581,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
581,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
581,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
581,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
581,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
581,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
581,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
582,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
582,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
582,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
583,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
583,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
583,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
584,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
585,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
586,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
586,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
586,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
587,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
587,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
588,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
588,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
589,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
589,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
590,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
590,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
591,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
591,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
592,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
592,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
593,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
593,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
594,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
594,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
595,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
595,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
596,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
596,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
597,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
597,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
598,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
598,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
599,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
599,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
600,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
600,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
601,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
601,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
602,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
602,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
603,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
604,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
604,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
605,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
605,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
606,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
606,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
607,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
607,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
608,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
608,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
609,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
609,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
610,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
610,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
611,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
611,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
612,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
612,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
613,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
613,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
614,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
614,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
615,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
615,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
616,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
616,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
616,3,Arterial stenosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
616,4,Carotid artery dissection,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
616,5,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
616,6,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
616,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
616,8,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
616,9,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
616,10,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
616,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
616,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
617,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
617,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
618,1,Headache,Headaches NEC,Headaches,Nerv,N
619,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
619,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
619,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
619,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
619,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
620,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
621,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
622,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
623,2,Laryngeal cancer stage IV,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
623,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
623,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
623,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
623,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
623,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
623,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
623,9,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
623,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
623,11,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
623,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
624,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
625,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
626,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
627,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
627,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
628,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
629,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
630,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
631,1,Blood follicle stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
631,2,Blood luteinising hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
631,3,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
632,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
632,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
632,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
633,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
634,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
634,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
635,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
636,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
637,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
637,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
638,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
638,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
639,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
639,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
640,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
640,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
641,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
641,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
641,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
642,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
642,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
642,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
643,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
643,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
644,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
645,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
646,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
646,2,Headache,Headaches NEC,Headaches,Nerv,N
647,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
648,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
648,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
649,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
650,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
651,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
652,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
653,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
653,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
654,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
655,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
656,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
656,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
657,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
658,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
659,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
659,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
659,3,Stoma site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
659,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
660,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
661,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
662,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
662,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
663,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
664,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
664,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
665,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
665,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
666,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
666,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
666,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
667,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
667,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
668,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
669,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
670,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
670,2,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
670,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
671,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
671,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
672,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
672,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
673,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
673,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
674,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
674,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
674,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
675,1,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
676,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
676,2,Deafness,Hearing losses,Hearing disorders,Ear,N
676,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
676,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
676,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
676,6,Headache,Headaches NEC,Headaches,Nerv,N
676,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
676,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
676,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
676,10,Ovarian disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
676,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
676,12,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
676,13,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
676,14,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
676,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
677,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
677,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
678,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
679,1,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
679,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
680,1,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
680,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
680,3,Headache,Headaches NEC,Headaches,Nerv,N
680,4,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
680,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
680,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
682,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
683,1,Axillary vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
684,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
685,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
686,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
687,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
687,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
688,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
689,1,Anastomotic leak,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
689,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
690,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
690,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
690,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
690,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
690,5,Non-small cell lung cancer stage IIIB,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
690,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
690,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
690,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
691,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
691,2,Ischaemic limb pain,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
691,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
692,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
692,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
692,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
692,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
692,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
692,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
692,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
693,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
693,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,3,Headache,Headaches NEC,Headaches,Nerv,N
693,4,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
693,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
693,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
693,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
693,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
694,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
694,2,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
695,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
695,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
695,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
695,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
695,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
695,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
695,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
696,1,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
696,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
696,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
696,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
697,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
698,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
699,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
699,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
700,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
701,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,2,Deafness,Hearing losses,Hearing disorders,Ear,N
701,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
702,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
702,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
702,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
703,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
703,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
703,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
703,4,Non-small cell lung cancer metastatic,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
703,5,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
704,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
704,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
705,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
706,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
707,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
707,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
707,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
708,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
708,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
708,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
709,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
709,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
710,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
710,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
710,3,Renal salt-wasting syndrome,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
710,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
710,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
711,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
711,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
711,3,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
711,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
711,5,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
711,6,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
711,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
711,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
711,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
711,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
711,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
711,12,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
711,13,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
711,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
712,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
713,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
714,1,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
714,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
714,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
714,4,Radiation associated haemorrhage,Radiation injuries,Injuries by physical agents,Inj&P,N
715,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
716,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
717,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
717,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
718,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
718,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
719,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
719,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
720,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
720,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
721,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
721,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
722,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
722,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
723,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
723,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
723,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
723,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
723,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
723,6,Bedridden,Disability issues,Lifestyle issues,SocCi,N
723,7,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
723,8,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
723,9,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
723,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
723,11,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
723,12,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
723,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
723,14,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
723,15,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
723,16,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
723,17,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,18,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
723,19,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
723,20,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,21,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
723,22,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
723,23,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
723,24,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
723,25,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
723,26,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
723,27,Headache,Headaches NEC,Headaches,Nerv,N
723,28,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
723,29,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
723,30,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
723,31,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
723,32,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
723,33,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
723,34,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
723,35,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
723,36,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
723,37,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,38,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
723,39,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
723,40,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
723,41,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
723,42,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,43,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
723,44,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,45,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
723,46,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
723,47,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
723,48,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
723,49,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
723,50,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
723,51,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
723,52,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
723,53,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,54,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,55,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
723,56,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
724,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
724,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
724,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
725,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
725,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
725,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
725,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
726,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
727,1,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
727,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
728,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
729,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
729,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
729,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
730,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
731,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
732,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
732,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
733,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
734,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
734,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
735,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
735,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
735,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
736,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
736,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
736,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
736,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
736,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
736,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
737,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
737,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
737,4,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
737,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
738,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
739,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
739,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
739,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
739,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
739,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
739,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
739,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
739,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
739,9,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
739,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
739,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
739,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
739,13,Headache,Headaches NEC,Headaches,Nerv,N
739,14,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
739,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
739,16,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
739,17,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
739,18,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
739,19,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
739,20,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
739,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
739,22,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
740,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
741,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
742,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
743,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
744,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Cortical visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
745,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
746,1,Cortical visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
746,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
746,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
747,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
748,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
749,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
750,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
750,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
751,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
751,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
752,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
752,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
753,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
754,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
754,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
754,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
754,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
754,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
754,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
754,7,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
754,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
754,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
754,10,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
755,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
756,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
756,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
756,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
756,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
756,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
757,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
757,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
757,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
757,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
757,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
758,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
758,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
758,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
758,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
759,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
760,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
761,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
761,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
761,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
761,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
761,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
761,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
762,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
762,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
762,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
762,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
762,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
763,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
763,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
763,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
763,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
763,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
763,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
763,7,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
763,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
763,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
763,10,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
764,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
764,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
764,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
764,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
764,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
764,6,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
764,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
765,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
765,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
766,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
766,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
766,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
766,4,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
766,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
766,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
767,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
767,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
768,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
769,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
769,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
769,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
770,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
770,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,1,Intracranial tumour haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
772,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
772,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
772,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
773,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
773,2,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
773,3,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
774,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
775,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
776,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
776,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
777,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
777,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
778,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
778,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
778,3,Hand-eye coordination impaired,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
778,4,Headache,Headaches NEC,Headaches,Nerv,N
778,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
778,6,Middle cerebral artery stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
779,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
779,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
779,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
781,1,Aortic embolus,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
782,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
783,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
783,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
784,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
785,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
785,2,Neurofibromatosis,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
786,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
786,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
787,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
788,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
788,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
789,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
789,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
789,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
790,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
791,1,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
791,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
791,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
792,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
793,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
794,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
795,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
796,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
796,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
796,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
796,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
796,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
796,6,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
796,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
796,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
796,9,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
797,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
797,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
797,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
797,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
797,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
798,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
798,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
799,1,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
799,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
800,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
800,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
801,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
801,2,Secretory adenoma of pituitary,Hormone secreting pituitary neoplasms,Endocrine neoplasms malignant and unspecified,Neopl,N
802,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
802,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
803,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
804,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
805,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
806,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
807,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
807,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
808,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
808,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
808,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
808,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
809,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
809,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
809,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
809,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
809,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
810,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
810,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
810,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
810,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
811,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
811,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
812,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
813,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
813,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
813,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
813,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
813,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
814,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
815,1,Decorticate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
815,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
815,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
815,4,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
816,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
816,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
816,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
816,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
816,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
816,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
816,7,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
816,8,Testicular germ cell cancer metastatic,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
816,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
817,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
818,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
818,2,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
818,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
819,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
820,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
820,2,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
820,3,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
820,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
820,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
821,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
821,3,Hypochloraemia,Chloride imbalance,Electrolyte and fluid balance conditions,Metab,N
821,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
821,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
821,6,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
822,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
822,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
823,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
823,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
824,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
824,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
824,3,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
824,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
824,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
825,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
826,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
827,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
827,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
828,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
829,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
829,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
830,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
830,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
830,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
831,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
831,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
831,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
831,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
831,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
831,6,Hypocapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
831,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
831,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
831,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
831,10,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
832,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
832,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
832,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
832,4,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
832,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
832,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
833,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
833,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
833,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
834,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
835,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
836,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
837,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
838,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
838,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
838,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
839,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
839,2,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
840,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
840,2,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
840,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
841,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
841,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
842,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
842,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
842,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
842,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
842,5,Tumour perforation,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,Y
843,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
843,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
844,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
844,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
845,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
845,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
845,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
846,1,Amylase decreased,Digestive enzymes,Gastrointestinal investigations,Inv,N
846,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
846,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
846,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
846,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
846,6,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
846,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
846,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
846,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
846,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
846,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
846,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
846,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
846,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
847,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
847,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
848,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
848,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
849,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
849,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
851,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
852,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
853,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
854,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,Y
855,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
855,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
855,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
856,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
857,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
858,1,Amylase decreased,Digestive enzymes,Gastrointestinal investigations,Inv,N
858,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
858,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
858,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
858,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
858,6,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
858,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
858,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
858,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
858,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
858,11,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
858,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
858,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
859,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
859,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
860,1,Pharyngeal abscess,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
860,2,Staphylococcal abscess,Staphylococcal infections,Bacterial infectious disorders,Infec,N
861,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
861,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
862,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
863,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
863,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
863,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
863,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
863,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
864,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
864,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
865,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
865,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
865,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
865,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
865,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
865,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
866,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
866,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
866,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
866,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
866,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
866,6,Hypocapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
866,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
866,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
866,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
866,10,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
867,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
867,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
867,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
867,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
868,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
868,2,Optic glioma,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
869,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
869,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
869,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
870,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
871,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
871,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
872,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
872,2,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
872,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
872,4,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
873,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
874,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
875,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
875,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
875,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
876,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
877,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
877,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
877,3,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
878,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
878,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
878,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
878,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
879,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
879,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
879,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
879,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
880,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
880,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
880,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
880,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
881,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
882,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
882,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
883,1,Headache,Headaches NEC,Headaches,Nerv,N
883,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
883,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
884,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
885,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
885,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
885,3,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
885,4,Funnel chest acquired,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
885,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
885,6,Pleural fibrosis,Pleural conditions NEC,Pleural disorders,Resp,N
885,7,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
885,8,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
885,9,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
885,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
886,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
886,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
886,3,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
886,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
886,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
886,6,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
887,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
888,1,Deafness,Hearing losses,Hearing disorders,Ear,N
888,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
888,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
889,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
889,2,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
889,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
889,4,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
889,5,Oesophageal mucosa erythema,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
889,6,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
889,7,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
889,8,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
889,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
890,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
890,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
890,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
890,4,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
890,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
890,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
891,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
891,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
892,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
893,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
893,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
893,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
894,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
894,2,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
895,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
896,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
896,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
897,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
897,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
898,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
898,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
898,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
898,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
898,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
898,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
899,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
900,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
900,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
901,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
902,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
902,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
903,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
903,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
903,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
903,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
903,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
903,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
903,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
903,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
903,9,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
903,10,Testicular germ cell cancer metastatic,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
903,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
904,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
904,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
904,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
905,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
905,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
905,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
906,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
907,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
908,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
908,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
909,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
910,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
910,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
911,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
911,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
911,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
912,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
913,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
913,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
914,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
915,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
916,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
916,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
917,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
917,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
917,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
917,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
917,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
917,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
917,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
917,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
917,9,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
917,10,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
917,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
917,12,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
917,13,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
917,14,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
917,15,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
917,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
918,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
918,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
919,1,Aortitis,Aortic infections and inflammations,Vascular infections and inflammations,Vasc,N
919,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
920,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
920,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
921,1,Choroidal effusion,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
921,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
922,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
922,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
923,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
923,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
924,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
924,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
924,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
924,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
924,5,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
925,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
926,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
926,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
926,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
926,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
926,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
926,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
926,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
926,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
926,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
927,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
927,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
928,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
928,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
928,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
929,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
929,2,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
930,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
930,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
930,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
930,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
930,5,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
930,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
930,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
931,1,Metastases to the mediastinum,Metastases to specified sites,Metastases,Neopl,N
931,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
931,3,Thymus enlargement,Thymus disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
932,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
932,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
932,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
933,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
934,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
934,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
934,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
934,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
934,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
934,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
935,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
936,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
936,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
936,3,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
936,4,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
936,5,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
936,6,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
936,7,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
937,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
938,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
938,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
939,1,Oroticaciduria,Disorders of pyrimidine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
940,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
940,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
940,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
940,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
940,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
940,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
941,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
941,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
941,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
941,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
941,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
942,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
942,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
942,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
942,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
944,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
944,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
944,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
944,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
945,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
946,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
946,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
946,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
947,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
948,1,Epithelioid mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
948,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
948,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
949,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
949,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
949,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
950,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
951,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
951,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
952,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
952,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
953,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
953,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
953,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
954,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
954,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
954,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
954,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
954,5,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
954,6,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
954,7,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
955,1,Granulomatous lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
955,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
955,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
955,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
955,5,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
955,6,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
955,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
957,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
957,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
957,3,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
957,4,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
957,5,Low cardiac output syndrome,Heart failures NEC,Heart failures,Card,N
957,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
957,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
957,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
957,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
957,10,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
958,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
958,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
959,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
960,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
960,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
960,3,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
961,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
961,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
961,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
961,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
962,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
962,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
962,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
962,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
963,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
963,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
963,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
964,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
964,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
964,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
964,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
965,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
966,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
967,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
968,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
968,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
968,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
968,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
969,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
970,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
970,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
971,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
972,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
972,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
972,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
972,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
973,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
973,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
974,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
974,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
974,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
974,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
975,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
975,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
976,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
977,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
978,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
978,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
979,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
979,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
979,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
979,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
979,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
979,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
980,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
981,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
981,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
981,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
982,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
982,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
982,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
983,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
984,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
984,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
984,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
984,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
984,5,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
985,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
985,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
985,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
986,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
986,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
987,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
988,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
988,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
989,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
989,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
989,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
989,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
989,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
990,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
990,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
991,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
992,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
992,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
993,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
994,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
994,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
995,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
995,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
995,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
995,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
995,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
996,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
996,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
997,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
997,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
998,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
999,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
999,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1000,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1000,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1000,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1000,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1000,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1000,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1000,7,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1000,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1000,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1000,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1000,11,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1000,12,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1000,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1000,14,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1000,15,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1000,16,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1001,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1001,2,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
1001,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1001,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1001,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1002,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1003,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1004,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1004,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1005,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1006,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1007,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1007,2,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1008,1,Epithelioid mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
1008,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1008,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1008,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1009,1,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1009,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1010,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1010,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1011,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1011,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1011,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1011,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1011,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1011,6,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1012,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1012,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1012,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1012,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1012,5,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1013,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1014,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1015,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1015,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1015,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1016,2,Non-Hodgkin's lymphoma stage IV,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1017,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1018,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1018,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1018,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1018,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1018,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1018,7,Headache,Headaches NEC,Headaches,Nerv,N
1018,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1018,9,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1018,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1018,11,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1018,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1018,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1018,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1018,15,Rectal prolapse,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1018,16,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1018,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1019,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1020,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1020,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1020,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1020,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1021,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1021,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1021,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1021,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1021,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1022,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1022,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1023,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1024,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1024,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1025,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1025,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1025,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1026,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1026,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1027,1,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
1028,1,Acquired gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1028,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1028,3,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1029,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1029,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1030,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1030,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1031,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1031,2,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1031,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1032,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1033,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1033,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1033,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1034,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
1034,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1034,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1035,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1035,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1035,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1035,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1036,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1036,2,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1037,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1037,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1037,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1038,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1039,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1040,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1041,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1041,2,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1042,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1043,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1043,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1044,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1045,1,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1045,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1046,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1047,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1047,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1048,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1048,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1048,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1049,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1049,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1049,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1050,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1050,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1050,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1051,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1051,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1051,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1052,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1053,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1053,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1054,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1054,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1054,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1055,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1056,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1057,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1058,1,Renal salt-wasting syndrome,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1059,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1059,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1059,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1060,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1060,2,Serous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1060,3,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1061,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1062,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1062,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1063,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1063,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1063,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1063,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1063,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1063,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1063,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1063,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1063,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1064,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1065,1,Serous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1066,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1067,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1067,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1068,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1069,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1069,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1069,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1069,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1069,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1069,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1069,7,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1069,8,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
1069,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1069,10,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,Y
1069,11,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1069,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1070,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1070,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1070,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1070,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1071,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1071,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1071,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1072,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,2,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1073,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1074,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1074,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1074,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1074,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1075,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1075,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1076,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1076,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1076,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1077,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1078,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1078,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1079,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1079,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1079,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1079,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1079,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1080,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
1081,1,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1082,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1082,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1082,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1082,4,Squamous cell carcinoma of the hypopharynx,Hypopharyngeal neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1082,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1082,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1083,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1083,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1083,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1083,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1083,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1084,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1084,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1084,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1084,4,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1085,1,Gitelman's syndrome,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
1086,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1086,2,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1087,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1087,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1087,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1087,4,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
1087,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1087,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1087,7,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1087,8,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1087,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1088,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1088,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1088,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1088,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1088,5,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1088,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1089,1,Angioimmunoblastic T-cell lymphoma recurrent,Angioimmunoblastic T-cell lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
1089,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1090,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1090,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1091,1,Infusion site bruising,Infusion site reactions,Administration site reactions,Genrl,N
1092,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1092,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1093,1,Cervix carcinoma recurrent,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1093,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1093,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1093,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1094,1,Pharyngeal perforation,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1095,1,Pharyngeal perforation,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1096,1,Urinary bladder toxicity,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1097,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1097,2,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
1098,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1098,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1098,3,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1098,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1098,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1098,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1098,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1098,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1098,9,Testicular germ cell tumour mixed stage II,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1098,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1098,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1099,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1100,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1101,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1101,2,Headache,Headaches NEC,Headaches,Nerv,N
1101,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1101,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1102,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1103,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1104,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1104,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1104,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1104,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1104,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1104,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1104,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1105,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1105,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1105,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1105,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1105,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1106,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1106,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1106,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1107,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1108,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1108,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1108,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1108,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1108,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1109,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1110,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1110,2,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1110,3,Resorption bone increased,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1111,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1112,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1112,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1112,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1112,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1112,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1112,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1112,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1113,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1113,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1114,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1115,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1115,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1115,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1116,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1117,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1118,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1118,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1118,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1118,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1119,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1119,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1120,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1121,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1122,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1123,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1123,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1124,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1124,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1124,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1124,4,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1125,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1125,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1125,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1125,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1125,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1125,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1125,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1126,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1127,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1128,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1129,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1130,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1130,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1131,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1131,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1131,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1132,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1132,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1133,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1133,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1134,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1134,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1134,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1134,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1135,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1135,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1136,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1136,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1136,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1136,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1136,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1136,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1136,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1136,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1137,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1138,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
1139,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1139,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1139,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1139,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1139,6,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
1139,7,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1139,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1139,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1139,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1139,11,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1139,12,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1139,13,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1139,14,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1139,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1139,16,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1139,17,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1139,18,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1139,19,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1139,20,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1139,21,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1140,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1140,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1140,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1140,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1140,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1140,6,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
1140,7,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1140,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1140,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1140,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1140,11,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1140,12,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1140,13,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1140,14,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1140,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1140,16,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1140,17,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1140,18,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1140,19,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1140,20,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1140,21,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1141,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1141,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1142,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1142,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1143,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1143,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1144,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1144,2,Deafness,Hearing losses,Hearing disorders,Ear,N
1144,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1144,4,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1145,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1145,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1145,3,Headache,Headaches NEC,Headaches,Nerv,N
1145,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1146,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1146,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1146,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1146,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1146,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1146,7,Tumour embolism,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1147,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1147,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1147,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1147,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1148,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1148,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1148,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1149,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1149,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1150,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1151,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1151,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1151,3,Headache,Headaches NEC,Headaches,Nerv,N
1151,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1151,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1152,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1153,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1153,2,DNA mismatch repair protein gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1153,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1154,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1154,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1155,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1155,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1156,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1156,2,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1156,3,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1156,4,Tumour embolism,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1157,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1157,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1158,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1159,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1159,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1160,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1160,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1160,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1161,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1161,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1161,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1162,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1162,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1162,3,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1162,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1163,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1163,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1163,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
1163,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1164,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1165,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1165,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1165,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1166,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1166,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1166,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1166,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1167,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1167,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1167,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1167,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1167,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1168,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1168,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1169,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1169,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1170,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1171,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1172,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1172,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1173,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1173,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1174,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1175,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1176,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1177,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1177,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1177,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1178,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
1178,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1178,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1178,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1178,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1178,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1178,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1179,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1180,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1181,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1181,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1181,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1182,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1182,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1182,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1183,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1184,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1185,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1186,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1186,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1187,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1188,1,Meningitis pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1188,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1188,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1188,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1188,5,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
1189,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1189,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1189,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1189,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1189,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1189,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1189,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1189,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1190,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1191,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1191,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1191,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1191,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1191,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1191,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1191,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1191,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1191,9,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1192,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1192,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1192,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1192,4,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
1193,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1194,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1195,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1196,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1196,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1197,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1197,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1197,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1197,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1197,5,Headache,Headaches NEC,Headaches,Nerv,N
1197,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1197,7,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1197,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1197,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1197,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1197,11,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1197,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1197,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1197,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1198,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1198,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1199,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1200,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1201,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1201,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1202,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1203,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1204,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1204,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1204,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1204,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1205,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1205,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1206,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1207,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1207,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1207,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1208,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1208,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
